The civic record
Read. Follow. Verify.Kentucky regulates controlled substance prescriptions and licensing boards
Last action · March 5, 2026: received in Senate to Committee on Committees (S)Sponsors: Tom Smith and 2 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Kentucky restricts practitioners from issuing prescriptions for s exceeding a three-day supply for acute pain, with specific medical exceptions. The measure also mandates reporting standards, criminal record checks, and expedited complaint reviews across state licensing boards.
Licensed healthcare practitioners face strict prescribing limits, mandatory continuing education requirements, and fingerprint-supported criminal background checks, while licensing boards must investigate complaints within specific timeframes.
- The General Assembly of the Commonwealth of Kentucky serves as the state's primary legislative body responsible for enacting statutory law. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
licensees authorized to prescribe or dispense controlled substances
Practitioners face new prescription supply limits, mandatory continuing education requirements, background check mandates, and expedited board investigations.
state licensing boards
Boards must promulgate administrative regulations, establish expedited complaint review procedures, consult with the Kentucky Office of Drug Control Policy, and conduct background checks.
patients receiving controlled substances
Patients experience revised prescription supply caps for acute pain along with established medical necessity documentation requirements for extended supplies.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What is the maximum supply a practitioner can prescribe for acute pain under this measure?
Are there exceptions to the three-day prescription limit for acute pain?
What continuing education requirements apply to practitioners?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · passed the House · in the Senate.
Procedural history
7 actions- Mar 5, 2026SenateIntroducedreceived in Senate to Committee on Committees (S)
- Mar 4, 2026HouseFloor3rd reading, passed 80-16
- Mar 3, 2026Houseposted for passage in the Regular Orders of the Day for Wednesday, March 04 2026
- Feb 26, 2026HouseFloor2nd reading, to Rules
- Feb 25, 2026Housereported favorably, 1st reading, to Calendar
- Feb 13, 2026HouseCommitteeto Licensing, Occupations, & Administrative Regulations (H)
Show 1 earlier action
- Feb 6, 2026HouseIntroducedintroduced in House to Committee on Committees (H)
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Mandatory Prescription Limits and Expedited Enforcement
The measure establishes a strict three-day cap for acute pain prescriptions alongside mandatory reporting timelines and expedited board investigations for controlled substance violations.
Connected Entities
Sources
apps.legislature.ky.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 75)
- Controversy40Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz35Current news / social attention level
Publisher tools
